Norgestimate and ethinyl estradiol NDC 79929-008

NDC codes

FDA NDC Directory

Product NDC (as listed)79929-008Labeler and product segments. Claims need a package NDC.

Product NDC at billing width79929-0008Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
79929-008-07	79929000807	3 CARTON in 1 CARTON (79929-008-07) / 1 KIT in 1 CARTONMarketed from Mar 31, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Norgestimate and ethinyl estradiol
Generic name (nonproprietary): norgestimate and ethinyl estradiol
Dosage form: Kit
Labeler: Naari Pte Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200384
Marketing start: Mar 31, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 79929-008_16bdb158-19c7-9c29-e063-6394a90a07ceSPL ID 16bdb158-19c7-9c29-e063-6394a90a07ceSPL set ID 03de435b-b8fb-4faa-a0ec-01e48b5aaae4RxCUI 240128, 748797, 749860

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N479929000807 followed by a unit qualifier and the quantity

Package 79929-0008-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 23, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Norgestimate and ethinyl estradiol tablets USP are estrogen/progestin COCs, indicated for use by women to prevent pregnancy. ( 1.1 ) 1.1 Oral Contraceptive Norgestimate and ethinyl estradiol tablets USP are indicated for use by females of reproductive potential to prevent pregnancy [see CLINICAL STUDIES ( 14 )].

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)